4. Sheffield Kidney Institute
5Whats
ā¢ What is this intervention FOR?
ā¢ What is the Evidence: VALIDITY ?
ā¢ What is the Relevance: UTILITY ?
ā¢ What is the RISK:BENEFIT?
ā¢ What is the COST:BENEFIT?
10. Sheffield Kidney Institute
5Whats
ā¢ What is this intervention FOR?
ā¢ What is the Evidence: VALIDITY ?
ā¢ What is the Relevance: UTILITY ?
ā¢ What is the RISK:BENEFIT?
ā¢ What is the COST:BENEFIT?
29. Sheffield Kidney Institute
and Maori/
ficant rela-
e mortality
cluded that
r death and
tive cohort
ty Wave II
nd that 5-y
0 compared
by log-rank
30 was not
ry recently,
and MHD
he USRDS
odels eval-
ity over 2 y
reas time-
odality for
FIGURE 3. Risk-adjusted survival curves for the 4 BMI (in kg/m2
)
categories at 5 y. The variables entered into the equation were age, sex,
hypertension, diabetes mellitus, left ventricular ejection fraction, hemody-
VANTAGES OF OBESITY IN DIALYSIS 547
Older Population with CHF
32. Sheffield Kidney Institute
Clinical scenario
ā¢ Mrs A on ESRD with a BMI of 35kg/mĀ² feels unwell since
trying to lose weight. Transplant surgeon tells her she
has to achieve a BMI of 30kg/mĀ² before being listed for a
transplant.
ā¢ She asks why she is being denied a transplant when her
friend with a pre-transplant BMI of 43kg/mĀ² was
successfully transplanted 10 years ago and has excellent
graft function
36. Sheffield Kidney Institute
Talk outline
ā¢ How does recipient obesity impact on post-
transplant outcomes?
ā¢ Is weight loss on dialysis safe?
ā¢ Transplantation or dialysis for the obese?
KEY POINTS
37. Sheffield Kidney Institute
Recipient obesity associated with delayed
graft function
ā¢ 11,386 HD patients
underwent transplant
ā¢ 2001-2006
ā¢ High BMI associated
with a higher risk of
DGF
Molnar MZ et al. Kidney Int. 2011; 80(2) 218-24.
38. Sheffield Kidney Institute
Relationship between graft loss and BMI at
transplant
ā¢ ANZDATA Registry data 1991-
2004
ā¢ Univariate analysis of 5684
patients
Chang, SH et al Transplantation. 2007. 84(8):981-987.
39. Sheffield Kidney Institute
Relationship between Graft loss and BMI
at Transplantation
Chang, SH et al Transplantation. 2007. 84(8):981-987.
Obesity NOT associated with increased risk of graft loss or death
40. Sheffield Kidney Institute
Risk factors for Graft Failure
Following Transplantation
Gore et al. American Journal of Transplantation. 2006;6:357-63
41. Sheffield Kidney Institute
Obesity and Outcome Following Transplantation
ā¢ UNOS data. 1997-1999
ā¢ 27,377 recipients
Gore et al. American Journal of Transplantation. 2006;6:357-63
42. Sheffield Kidney Institute
Pre-transplant BMI and mortality
ā¢ 10,090 HD patients
transplanted 2001-
2007 in USA
ā¢ 5 year follow up
Obesity NOT associated with increased risk of graft loss
or death
45. Sheffield Kidney Institute
Talk outline
ā¢ How does recipient obesity impact on post-
transplant outcomes?
ā¢ Is weight loss on dialysis safe?
ā¢ Transplantation or dialysis for the obese?
KEY POINTS
47. Sheffield Kidney Institute
High BMI does not associate with mortality in
Hemodialysis patients waitlisted for transplant
Molnar MZ et al. American Journal of Transplantation. 2011; 11(4) 725-736.
ā¢ 14,632 HD patients
ā¢ 6 year registry data
ā¢ High BMI associated
with a lower risk of
mortality
48. Sheffield Kidney Institute
Weight loss in Transplant Waitlisted Maintenanceā
Hemodialysis Patients associates with mortality
ā¢ 14,632 HD patients
ā¢ 6 year registry data
ā¢ Case-mix adjusted
ā¢ Weight loss prior to
transplantation associated with
higher risk of mortality
Molnar MZ et al. American Journal of Transplantation. 2011; 11(4) 725-736.
49. Sheffield Kidney Institute
Pre-transplant muscle mass and outcomes
post transplant
ā¢ 10,090 HD patients
transplanted 2001-
2007 in USA
ā¢ 5 year follow up
Preserved muscle mass associates with improved
outcomes
50. Sheffield Kidney Institute
Pretransplant Serum Albumin with Post Transplantā
Outcomes in Kidney Transplant Recipients
Molnar MZ et al. American Journal of Transplantation. 2011;11(5) 1006-1015
ā¢ 8,691 HD patients
ā¢ 2001-2006
ā¢ Case mix adjusted
ā¢ Low pre-transplant albumin
associated with higher risk o
DGF, mortality, graft-failure
51. Sheffield Kidney Institute
Talk outline
ā¢ How does recipient obesity impact on post-
transplant outcomes?
ā¢ Is weight loss on dialysis safe?
ā¢ Transplantation or dialysis for the obese?
KEY POINTS
52. Sheffield Kidney Institute
Conclusions
ā¢ Obesity is associated with increased risk of DGF and
wound infections
ā¢ No evidence that weight loss prior to transplantation
positively impacts on post- transplant outcomes and may
be harmful.
ā¢ Transplantation in obese patients associated with
survival advantage compared to haemodialysis.
ā¢ Impact of obesity on graft and patient survival
comparable to other recipient comorbidities such as
diabetes
60. Sheffield Kidney Institute
5Whats
ā¢ What is this intervention FOR?
ā¢ What is the Evidence: VALIDITY ?
ā¢ What is the Relevance: UTILITY ?
ā¢ What is the RISK:BENEFIT?
ā¢ What is the COST:BENEFIT?
The first WHAT consist of asking WHAT is the intervention/test/investigation forā¦.was it justified?
What was the primary endpoint of a RCT?
What were the secondary endpoints?
What did the study aim to achieve?
The first WHAT consist of asking WHAT is the intervention/test/investigation forā¦.was it justified?
What was the primary endpoint of a RCT?
What were the secondary endpoints?
What did the study aim to achieve?
Univariate relationship between hazard for graft loss (mean Ā± 95% confidence intervals) and BMI at transplant. U shaped curve (BMI ā„30.0 kg/mĀ²)
The first WHAT consist of asking WHAT is the intervention/test/investigation forā¦.was it justified?
What was the primary endpoint of a RCT?
What were the secondary endpoints?
What did the study aim to achieve?